
The National Institute for Drug and Food Surveillance (INVIMA) warns of the counterfeiting of the medicine Tagrisso (Osimertinib) 80mg, lot FKHD and expiration date 04/2024. The counterfeiting of the product was reported by the holder of the sanitary registration ASTRAZENECA COLOMBIA S.A.S.
Lot FKHD with manufacturing date 02/2024 is a genuine Tagrisso lot number supplied to Colombia by AstraZeneca. The counterfeit product has inconsistencies in the artwork, typography, packaging font and an incorrect font for the lot coding. Likewise, the thickness of the box is different from that of the original and the opening tab is on the wrong side.

